TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ILMN

Illumina Inc

Healthcare · Diagnostics & Research

270.00$ -1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ILMN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
26.9% 29.7% 28.7% 31.8% 34.3% 29.7% 33.3% 12.0% 8.6% 10.6% 19.1% 24.9%
6.0% 5.7% 5.9% 5.7% 5.4% 5.3% 5.8% 5.5% 8.6% 9.6% 8.1% 6.2%
8.2% 6.0% 5.4% 6.0% 5.8% 5.5% 6.0% 16.7% 8.0% 8.4% 8.5% 6.3%
2.9% 3.4% 5.6% -6.7% 4.7% 3.0% 3.8% -6.4% 88.8% – – –
-3.0% -1.7% -1.9% 7.1% -0.5% -5.5% 2.3% -3.4% 4.5% -2.0% -11.0% -3.5%
7.6% 6.5% 11.3% 11.3% 8.9% 5.9% 5.8% 4.6% 6.2% 4.3% 2.9% 3.4%
-21.8% -4.8% -21.5% -7.8% -54.4% 21.0% -17.1% -23.6% -12.9% -5.1% -4.1% -1.3%
60.8% 0.0% 0.5% 0.2% 22.1% – – 11.3% 20.4% – – –
-12.7% -12.4% -10.4% -9.1% -6.0% -9.1% -22.7% -11.3% -1.2% -0.9% -2.7% -17.1%
-7.6% -11.0% -2.5% -0.1% 21.9% -15.5% 14.5% 10.4% 21.6% -27.4% 11.2% -0.1%
-9.0% -18.9% -8.5% -6.4% 17.8% -25.3% -23.6% -1.1% 21.8% -26.9% -13.0% -17.2%
-4.1% 6.0% -1.4% 17.8% -2.4% 25.3% -7.2% -12.8% 17.0% -21.4% 1.8% 6.7%
19.3% 23.3% 17.3% 20.5% 25.4% 23.8% 27.5% 7.4% 2.3% 6.3% 16.2% 21.5%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?